References

 

1.   Miller K.M., Foster N.C., Beck R.W., Bergenstal R.M., DuBose S.N., DiMeglio L.A., ...& Tamborlane W.V. (2015). Current State of Type 1 Diabetes Treatment in the U.S.: Updated Date From the T1D Exchange Clinic Registry. Diabetes Care, 38 (6), 971-878.

2. Prime Group for JDRF. Type 1 Diabetes, 2010. JDRF, 2011

3.  International Diabetes Federation. (2015).  IDF Diabetes Atlas, (7th ed.).

4. Bell, K.J., Barclay, A.W., Petocz, P., Colagiuri, S., & Brand-Miller, J.C. (2014). Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol, 2 (2), 133-140.

5. Bell, K.J., Smart, C.E., Steil, G.M., Brand-Miller J.C., King, B., & Wolpert, H.A. (2015) Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era. Diabetes Care, 38 (6), 1008-1015.

6. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, ...& Thorsteinsson B. (2004). Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.  Diabetes Metab Res Rev., 20 (6), 479-486.

7. Tao B, Pietropaolo M, Atkinson M, Schatz D, & Taylor D. (2010). Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS One, 5 (7), e11501.

8. Livingstone S.J., Levin D., Looker H.C., Lindsay R.S., Wild S.H., Joss N., ...& Colhoun H..M. (2015).  Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010. Journal of the American Medical Association, 313 (1), 37-44.